Pfizer, Oxford vaccines reduce severe COVID-19 in elderly: Study

The Pfizer and Oxford-AstraZeneca vaccines for COVID-19 are highly effective in reducing severe coronavirus infection among people aged 70 years and above, according to a study. The research, posted as a pre-print and yet to be peer-reviewed, estimated the effect of both the COVID-19 vaccines on the laboratory-confirmed symptomatic disease in individuals aged 70 years or older in England. The researchers, including those from Public Health England (PHE), compared the rate of hospitalisation and deaths in confirmed COVID-19 patients aged over 80 who were vaccinated more than 14 days before testing positive, with unvaccinated cases.

from IndiaTV India: Google News Feed https://ift.tt/3sFe2sv
via